Results per Page:
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Discovery of a hidden tumor suppressor in the genome of the virus that causes Merkel cell carcinoma
From the Galloway Lab, Human Biology Division
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
The ins and outs of the tumor microbiome
From the Bullman Lab, Human Biology Division and Johnston Lab, Vaccine and Infectious Disease Division
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
Could bacterial enzymes drive cancer formation by directly modifying human DNA?
W.M. Keck Foundation grant will help scientists pioneer new technologies to find out
Immune booster may awaken body’s defenses against skin cancer
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer
New guide helps clinicians navigate immunotherapy revolution in Merkel cell carcinoma
‘Real-world’ review accompanies new clinical care guidelines in rare skin cancer
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
Galloway receives NCI Outstanding Investigator Award
Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers